Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athersys Inc (NQ: ATHX )

2.380 USD +0.230 (+10.70%)
Streaming Delayed Price Updated: 6:37 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
64 Biggest Movers From Yesterday
Gainers Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares jumped 135.3% to close at $7.30 after the company received FDA ... 
Tags INO Movers From Yesterday QMCO
From Benzinga
Here's Why Athersys Stock Is Soaring Today
The stem cell stock jumped after a major Wall Street firm initiated coverage, but there's a catch. 
Tags Market News ATHX
From Motley Fool
Top Buys by Directors: Traub's $322.5K Bet on ATHX
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... 
Tags Stocks
From Market News Video
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares climbed 133% to $7.22 after the company received FDA clearance to ... 
Tags KBSF KERN KLR
From Benzinga
Afternoon Market Stats in 5 Minutes
Movers Indices • S&P 500 ETF (NYSE:SPY) fell 0.10% to $303.98. • Nasdaq ETF (NASDAQ:QQQ) increased 0.03% to ... 
Tags USO TLT EPAC
From Benzinga
Thursday's ETF Movers: XBI, EMLP
In trading on Thursday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares of Athersys, up about 26.8%... 
Tags ETFs
From ETF Channel
Thursday Sector Leaders: Grocery & Drug Stores, Biotechnology Stocks
In trading on Thursday, grocery & drug stores shares were relative leaders, up on the day by about 2%. Leading the group were shares of GNC Holdings, up about 28.2% and shares of Rite Aid up about... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For June 25, 2020
Upgrades Credit Suisse changed the rating forAllstate Corp(NYSE: ALL) from Underperform to Neutral. Allstate ... 
Tags ATHX PDCO Intraday Update
From Benzinga
20 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers • GNC Holdings, Inc. (NYSE:GNC) stock rose 58.56% to $0.97 during Thursday's pre-market session. • Kitov ... 
Tags TWST ATHX Markets
From Benzinga
Thinking about buying stock in SINTX Technologies, China Automotive Systems, Athersys Inc, Theratechnologies, or Biocept Inc?
InvestorsObserver issues critical PriceWatch Alerts for SINT, CAAS, ATHX, THTX, and BIOC. 
From PR Newswire
Add Up The Parts: IWO Could Be Worth $234
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Here's Why Athersys Rose 26.5% in May
The stem cell stock recovered from a lousy April as the company fed investors updates for its COVID-19 programs. 
Tags ATHX Market News MESO
From Motley Fool
Athersys Announces Upcoming Presentations at the International Society of Cell and Gene Therapy Virtual Conference
Athersys taking a leading role at the International Society of Cell ad Gene Therapy Conference and will discuss MultiStem and the ARDS clinical trial. 
From Business Wire News Releases
78 Biggest Movers From Yesterday
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares climbed 66.7% to close at $3.95 on Monday after the company highlighted ... 
Tags Energy REPH NVAX
From Benzinga
Athersys (ATHX) Q1 2020 Earnings Call Transcript
ATHX earnings call for the period ending March 31, 2020. 
Tags Market News ATHX
From Motley Fool
Athersys Reports First Quarter 2020 Results
Athersys Q1 Earnings reflects multiple achievements for the Company, including obtaining FDA authorization to initiate two additional clinical trials. 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags KIN ELAN SNDX
From Benzinga
33 Stocks Moving in Wednesday's Pre-Market Session
Gainers CPS Technologies Corporation (NASDAQ: CPSH) shares rose 116.5% to $2.43 in pre-market trading following Q1 results. CPS ... 
Tags News ATVI Pre/Market Outlook
From Benzinga
Look Under The Hood: IWV Has 14% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDS
The first patients have been enrolled in the Athersys COVID-19 induced ARDS clinical program using MultiStem cell therapy. 
From Business Wire News Releases
Here's Why Athersys Tumbled 23.3% in April
The stem cell stock has delivered a 100% gain since the beginning of the year. Can it hold? 
Tags ATHX Market News
From Motley Fool
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags JNCE OXFD KIDS
From Benzinga
20 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers • Medigus, Inc. (NASDAQ:MDGS) stock moved upwards by 70.21% to $4 during Friday's pre-market session. • ... 
Tags SNSS LMNX GILD
From Benzinga
32 Stocks Moving in Friday's Pre-Market Session
Gainers SPI Energy Co., Ltd. (NASDAQ: SPI) shares rose 37.6% to $1.28 in pre-market trading. SPI Energy reported receipt of notice ... 
Tags CURO EYES Premarket Movers
From Benzinga
Athersys and University Hospitals Cleveland Medical Center Announce Activation of the First Clinical Site for the MACOVIA Study, a Pivotal Phase 2/3 Study Evaluating MultiStem® Cell Therapy for COVID-
The first clinical site is now open for the MACOVIA study, a pivotal Phase 2/3 study evaluating MultiStem® cell therapy for COVID-19 induced ARDS 
From Business Wire News Releases
Athersys to Present at the Bank of America Merrill Lynch Virtual Healthcare Conference on May 14
Athersys presentation scheduled for May 14, 2020 at 8:20 AM EDT. A live webcast will be available at https://tinyurl.com/y73g9zud 
From Business Wire News Releases
Are Stem Cells the COVID-19 Treatment We've All Been Waiting For?
Promising results from a very small study caused shares of stem cell stocks to soar, but investors shouldn't get too carried away just yet. 
Tags Market News MESO PSTI
From Motley Fool
Market Briefing for Tuesday, April 28
We do know that every sector of S&P has firmed, and it (backed by the Fed) continues grinding higher within the target range we've had now for well over a month. That's a zone I've referred to as... 
Tags ETFs Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
81 Biggest Movers From Friday
Gainers Mesoblast Limited (NASDAQ: MESO) shares climbed 139.5% to close at $15.45 on Friday after the company reported 10 out of ... 
Tags CCLP LWAY INSE
From Benzinga
Athersys to Host First Quarter Financial Results Call
Athersys will release its first quarter 2020 financial results at approximately 4:00 PM Eastern Time on Thursday, May 7, 2020. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.